Results 211 to 217 of about 10,368 (217)

Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

Journal of the American Academy of Dermatology, 2021
Nikolai Dyrberg Loft, Emma Guttman-Yassky, ANNE-SOFIE Halling   +2 more
exaly  

Characterizing dupilumab facial redness: A multi-institution retrospective medical record review

Journal of the American Academy of Dermatology, 2020
Jane Grant-Kels, Steven Brett Sloan, Reid Waldman   +2 more
exaly  

Facial and neck erythema associated with dupilumab treatment: A systematic review

Journal of the American Academy of Dermatology, 2021
Vincent Piguet, Christine E Jo, Jensen Yeung   +2 more
exaly  

Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps

International Forum of Allergy and Rhinology, 2022
Eric Wang, Harish Dharmarajan, Stella Lee   +2 more
exaly  

Dupilumab’s duplicity

Journal of the American Academy of Dermatology
openaire   +2 more sources

Dupilumab for treatment of atopic dermatitis

Expert Review of Clinical Pharmacology, 2018
Andreas Wollenberg
exaly  

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Jamie Orengo, Wei Keat Lim, Jeanne Allinne   +2 more
exaly